Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study

PURPOSE: Oral mucositis (OM) is a side effect associated with cancer treatment. Hangeshashinto (HST), a Kampo medicine, was originally prescribed to treat diarrhea, gastritis, and stomatitis. Several reports have described the effects of HST for OM induced by chemotherapy in patients with gastric or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimatsu, Masako, Kawashita, Yumiko, Soutome, Sakiko, Murata, Maho, Sawayama, Yasushi, Kurogi, Tadafumi, Nakao, Noriko, Miyazaki, Yasushi, Umeda, Masahiro, Ukai, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657322/
https://www.ncbi.nlm.nih.gov/pubmed/37979045
http://dx.doi.org/10.1007/s00520-023-08175-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657322/
https://www.ncbi.nlm.nih.gov/pubmed/37979045
http://dx.doi.org/10.1007/s00520-023-08175-7

Ejemplares similares